Irinotecan Accord 20 mg/ml concentraat voor oplossing voor infusie

DRUG2 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Conditions

Gastric cancerGastric peritoneal metastases

Phase 1

Peri-operative intraperitoneal irinotecan and systemic FLOT in the curative treatment of gastric cancer and gastroesophageal junction cancer: a phase I study

Not yet recruitingCTIS2025-522864-34-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Gastric cancer

Target: 18Updated: 2026-03-16

Phase 2

Intraperitoneal irinotecan combined with systemic therapy for patients with gastric peritoneal metastases: A phase II, multicenter study

RecruitingCTIS2025-521468-36-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Gastric peritoneal metastases

Start: 2025-09-29Target: 49Updated: 2025-09-15